​
​

Aileron Therapeutics (ALRN) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Aileron Therapeutics Revenue Highlights

00

Aileron Therapeutics Revenue by Period

Aileron Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Aileron Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aileron Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$134.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--

Aileron Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aileron Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
CRISCuris$10.02M$2.55M
ASMBAssembly Biosciences$7.16M$6.84M
HSTOHistogen$3.77M$5.00K
SABSSAB Biotherapeutics$2.24M$263.14K
CBIOGyre Therapeutics$794.00K-
VCNXVaccinex$570.00K$52.00K
MGTADianthus Therapeutics$314.00K$72.00K
ABVCABVC BioPharma$152.43K$117.14K
APTXAptinyx--
BPTHBio-Path--
EVLOEvelo Biosciences--
TILInstil Bio--
BNTCBenitec Biopharma--
ALRNAileron Therapeutics--
FWBIEntero Therapeutics--
NLTXNeurogene--
GOVXGeoVax Labs-$300.68K
ARTLArtelo Biosciences--
NUVBNuvation Bio-$727.00K
SLRXSalarius Pharmaceuticals--

ALRN Revenue FAQ

What is Aileron Therapeutics’s yearly revenue?

Aileron Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ALRN's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Aileron Therapeutics’s quarterly revenue?

Aileron Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). ALRN's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Aileron Therapeutics’s revenue growth rate?

Aileron Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.